The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Cataract surgery is routinely performed with anesthesia care, whereas anesthesia care for other elective, low-risk, outpatient procedures is applied more selectively. We hypothesize that sublingual melatonin will provide superior anxiolysis and sedation while maintaining a high safety profile and minimizing hemodynamic
| Condition(s) | Cataract Surgery Anesthesia |
|---|---|
| Status | Recruiting |
| Phase | Phase 4 |
| Study type | Interventional |
| Summary | Cataract surgery is routinely performed with anesthesia care, whereas anesthesia care for other elective, low-risk, outpatient procedures is applied more selectively. We hypothesize that sublingual melatonin will provide superior anxiolysis and sedation while maintaining a high safety profile and minimizing hemodynamic disturbances. |
| Who can participate | Inclusion Criteria: * • Age ≥ 60 years * American Society of Anesthesiologists (ASA) physical status I-III * Scheduled for unilateral cataract surgery under local anesthesia * Ability to understand and complete study-related questionnaires Exclusion Criteria: * • Known allergy or hypersensitivity to melatonin * Chronic use of sedatives, hypnotics, or anxiolytics * History of sleep disorders or psychiatric illness * Visual or hearing impairment that would hinder communication * Emergency surgery or anticipated intraoperative complications |
| Ages | 60 Years |
| Sex | All |
| Lead sponsor | Al-Azhar University |
| Locations | Cairo, Egypt, Egypt; Baghdad, Baghdad Governorate, Iraq |
| Start date | 2025-09-01 |
| NCT ID | NCT07036367 |
| Official listing | https://clinicaltrials.gov/study/NCT07036367 |